Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to -$30.9 million.

  • Accendra Health's Net Cash Flow rose 8451.54% to -$30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.4 million, marking a year-over-year increase of 8336.3%. This contributed to the annual value of -$222.6 million for FY2024, which is 21961.84% down from last year.
  • Accendra Health's Net Cash Flow amounted to -$30.9 million in Q3 2025, which was up 8451.54% from $16.4 million recorded in Q2 2025.
  • Accendra Health's 5-year Net Cash Flow high stood at $226.0 million for Q2 2023, and its period low was -$199.5 million during Q3 2024.
  • Its 5-year average for Net Cash Flow is -$4.4 million, with a median of -$3.3 million in 2023.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 150616.87% in 2022, then skyrocketed by 72910.05% in 2025.
  • Quarter analysis of 5 years shows Accendra Health's Net Cash Flow stood at $17.0 million in 2021, then tumbled by 154.52% to -$9.3 million in 2022, then soared by 332.9% to $21.6 million in 2023, then plummeted by 212.77% to -$24.4 million in 2024, then dropped by 26.59% to -$30.9 million in 2025.
  • Its last three reported values are -$30.9 million in Q3 2025, $16.4 million for Q2 2025, and $9.5 million during Q1 2025.